Updated Safety & Antileukemic Activity Data of Sonrotoclax (Sonro; BGB-11417), a Potent and Selective B-cell lymphoma 2 (BCL2) Inhibitor, in Treatment-Naive (TN) Patients (Pts) With Acute Myeloid Leukemia (AML) Unft for Intensive Chemotherapy

Autores de IIS La Fe

• Pau Montesinos Fernández

  Autor

Participantes ajenos a IIS La Fe

• Jentzsch, M.
• Shortt, J.
• Fong, C. Y.
• Leitch, S.
• Murthy, G. S. Guru
• Tan, S. Y.
• Huang, X.
• Platzbecker, U.
• Dinardo, C.
• Shi, Z.
• Mundra, V.
• Li, R.
• Liu, Y.
• Zernovak, D.
• Agarwal, A.
• Wei, A. H.

Grupos

• Hematología y Hemoterapia

Abstract

Abstract no disponible